25-Jan-2023 By Ben Hargreaves
The company confirms that its ‘An Accord for a Healthier World’ initiative will be rolled out to 45 lower-income countries.
11-Aug-2022 By Jenni Spinner
A leader from the behavioral science specialist shares ways to use precision engagement and other methods to increase patient adherence in clinical studies.
26-Mar-2019 By Maggie Lynch
Nanotechnology may be able to increase bioavailability in low-solubility drugs and improve a drug’s chance of success, according to Ascendia CEO.
24-May-2017 By Flora Southey
The University of Birmingham has developed a cell-penetrating peptide it claims could be used to make eye drop versions of age-related macular degeneration drugs currently delivered by injection.
02-Mar-2015 By Fiona BARRY
Clinical supply company Catalent has expanded its European facilities, citing growing demand for cold-chain and highly potent products.
08-Jan-2015 By Dan Stanton
Regulatory enforcement saw fewer counterfeit drug websites in 2014 but sellers are turning to YouTube and social media sites to advertise their products, according to the MHRA.
15-May-2014 By Anthony King
Chemists at MIT have created a triple warhead against cancer. They believe theirs is the first example a polymer nanoparticle which carries a precise ratio of three drugs that can be released in response to three distinct triggers.
12-May-2014 By Dan Stanton
The counterfeiting of over-the-counter drugs is a growing problem according to an ex-criminal prosecutor, but the nature of such medicines means the problem often goes unreported.
26-Feb-2014 By Zachary Brennan
Pharma industry employees and wholesalers with access to narcotic APIs would be subject to background checks and drug testing under new proposals being considered in the US.
30-Sep-2013 By Zachary Brennan
The US House on Saturday passed legislation that calls for the tracking and tracing of pharmaceuticals through the nation's supply chain after agreeing on the bill with the Senate last week.
02-Apr-2013 By Dan Stanton
The global rise in counterfeit medicine and illegal online pharmacies is a regulatory ongoing battle, according to the MHRA.
USP launches database to tackle poor-quality drugs
The US Pharmacopeia (USP) has launched a free, public database of its drug testing to improve surveillance of poor-quality medicines.
13-Sep-2010 By Claire Videau and Gareth Macdonald
Scientists say counterfeit drug and ingredient detection using NQR could benefit both manufacturers and pharmacies.
Biologics market worth $158bn by 2015, new report
Improving safety and efficacy coupled with drug industry desire for “stronger” patents will drive growth of the biologics sector over the next five years, according to new research.
European fake drug market worth €10.5bn, says Pfizer sponsored study
Counterfeit drugs worth €10.5bn ($14.3bn) are sold in Europe each year with Germans and Italians being the biggest consumers of such products, according to new Pfizer sponsored research.
Novartis buys HySolv technology from BTG
Swiss drug major Novartis will UK specialty pharma firm BTG up to $10m (€7m) for its HySolv drug delivery technology.
Nigerian counterfeit drug seizure
29-May-2008 By Nick Taylor
A 20ft container of counterfeit pharmaceuticals has been impounded
by the Nigerian National Agency for Food and Drug Administration
and Control (NAFDAC).
Small molecules still leading the way into the clinic
Annual round up of all drugs entering Phase I
20-Dec-2007 By Mike Nagle
DrugResearcher.com brings you its annual round up of all the drugs
that entered clinical development in 2007.
Paediatric drugs and testing highlighted
26-Nov-2007 By Katrina Megget
The importance of paediatric drug formulations and clinical trials
in children was highlighted at this month's American Association of
Pharmaceutical Scientists (AAPS) conference in San Diego.
New firm to tackle poor solubility head on
07-Nov-2007 By Anna Lewcock
A new Belgian company has joined the throng of pharmas tapping into
the booming drug delivery business, but claims that its unique
technologies will carve it a place as one of the industry's key
Survey asks: what to do about counterfeit drugs?
30-Oct-2007 By Katrina Megget
Action should be taken to curb the counterfeit drug trade, but not
via legal intervention, the results of a European survey say.
Pseudoephedrine drugs still OTC
03-Sep-2007 By Katrina Megget
Reformulations of pseudoephedrine- and ephedrine-containing drugs
in the UK look unlikely following the announcement of less extreme
restrictions on the sale of the pharmaceuticals.
Indian drug manufacturers must clean up their act
28-Aug-2007 By Kirsty Barnes
New research has branded pharmaceutical manufacturers in India as
being responsible for the release of substantial and worrying
amounts of active pharmaceutical ingredients (APIs) into the
Illuminating the future of drug delivery
02-Aug-2007 By Dr Matt Wilkinson
Irish researchers have developed a technique that could be used to
deliver controlled amounts of drugs to diseased tissues while
minimising side effects simply by shining light on the target.
China continues steps toward drug safety reform
31-Jul-2007 By Kirsty Barnes
China continues to take steps toward drug safety reforms as it
forges closer ties with US regulators and shuts down dodgy
The 'global disaster' of fake internet pharmacies
19-Jul-2007 By Katrina Megget
Fake internet pharmacies are a growing "global disaster"
with increasingly dangerous consequences, pharmaceutical industry
Is Amgen turning into a big pharma?
07-Jun-2007 By Emilie Reymond
Biotech titan Amgen announced yesterday the acquisition of a small
molecule developer - the second buyout of this type in less than a
Amgen bolsters portfolio in kidney disease via $420m buy
05-Jun-2007 By Cristina Jimenez-Andres
Amgen will strengthen its drug portfolio aimed at fighting renal
disease after agreeing to acquire Ilypsa, a private biotechnology
company which is developing a novel drug for the treatment of
elevated blood phosphate (hyperphosphataemia)...
Drugging the 'undruggable'
30-May-2007 By Mike Nagle
Over 50 per cent of proteins in the body are considered too
difficult to target with drugs; they are 'undruggable'. Yet it is
exactly these molecules US pharma firm Avalon is focussing on.
New product makes counterfeiting 'virtually impossible'
02-May-2007 By Anna Lewcock
A new machine developed by US firm Vardex Laser promises to offer a
unique solution to the global problem of drug counterfeiting,
protecting products right down to the pill itself.
Amgen CFO walks away
12-Apr-2007 By Emilie Reymond
Amgen is seeing its chief financial officer (CFO) walk away while
the Californian biotech giant tries to heal its wounds after a
Drug imports debate rumbles on
08-Mar-2007 By Anna Lewcock
Proposed legislation to allow cheap drug imports into the US met
with opposition this week as representatives from the
pharmaceutical industry resisted the move saying there are
'better, safer alternatives' to imported drugs.
Flood of fake drugs must be stopped, warns UN
05-Mar-2007 By Emilie Reymond
The flood of fake drugs now available in many countries must be
tackled as it could have fatal consequences for consumers, a new UN
Indian-Irish biosimilar partnership to provide new European CMO contracts
13-Feb-2007 By Kirsty Barnes
A new partnership between India's Reliance Life Sciences (RLS) and
Ireland's GeneMedix will provide new contract opportunities for
European contract bio-manufacturers.
Predictive tool could save pharma billions
02-Feb-2007 By Mike Nagle
A tool that predicts which experimental drugs will ultimately be
approved for release could cut development costs by nearly 40 per
cent, saving pharma companies hundreds of millions per new drug.
GAO bemoans lack of new drugs
03-Jan-2007 By Mike Nagle
A US government report has warned that the pharmaceutical industry
is not producing enough new drugs despite spending more on research
Nanoparticles to treat drug overdoses
19-Dec-2006 By Emilie Reymond
Researchers have discovered that using nanotechnology could help
reduce fatalities from drug overdoses, as nanoparticles can act as
Fake Lipitor lingers in supply chain
24-Jul-2006 By Gregory Roumeliotis
Pfizer has issued another recall for packs of its blockbuster
cholesterol drug Lipitor after UK regulators found evidence of more
counterfeit product in the legitimate supply chain from a batch
whose withdrawal was supposed to have...
New lab test identifies cancer drug efficacy
15-Jun-2006 By Wai Lang Chu
A new laboratory test that identifies patients who benefit most
from targeted cancer drugs was the talk of the annual meeting of
the American Society of Clinical Oncology (ASCO) as the test's
accuracy is sure to save hundreds...
A nudge but no push towards RFID from the FDA
13-Jun-2006 By Gregory Roumeliotis
While praising the benefits of radio-frequency identification
(RFID), the US Food and Drug Administration (FDA) has refrained
from demanding its implementation in new measures it unveiled to
combat counterfeit drugs, asking instead...
FDA joins e-mail counterfeit drug alert service
13-Mar-2006 By Gregory Roumeliotis
The US Food and Drug Administration (FDA) has linked its
Counterfeit Alert Network (CAN) to SafeMeds Alert System, an
electronic mailing list backed by pharmaceutical manufacturers that
sends warnings about fake drugs to anyone who...
Bruker help Chinese fight counterfeit drugs
20-Jan-2006 By Wai Lang Chu
Bruker Optics have reached an agreement with the Chinese State Food
and Drug Administration (SFDA), which sees Bruker technology
integrated into regional Food and Drug Administration offices
aiding the fight against illegal counterfeit...
pSivida completes acquisition of US drug delivery firm
06-Jan-2006 By Kirsty Barnes
Australian company pSivida has completed its acquisition of US drug
delivery firm, Control Delivery Systems (CDS), as part of its
strategy to expand its presence in the US biotech industry.
Fake drug sales 'could nearly double by 2010'
14-Sep-2005 By Phil Taylor
A US think tank, The Centre for Medicines in the Public Interest,
has released a new report projecting counterfeit drug sales to
reach $75 billion in 2010, a 92 per cent increase from 2005.
FDA claims progress in battle against fake drugs
The US Food and Drug Administration (FDA) says it has made
significant progress in the battle against counterfeit prescription
Potential drug discovery for leishmaniasis
Scientists have discovered the antimonial drugs used to treat
Leishmaniasis focus on the same drug targets as those drugs used to
treat sleeping sickness and Chagas disease, raising the possibility
of a multi-functional drug that...
Therapeutic class determines drug development time
The cost and time required to develop a new drug and bring it to
market is determined by the therapeutic category of that drug. The
results are consistent with the model that predicts R&D efforts
are generally shifting toward...
Industry makes fake drug recommendations
In response to growing concerns about counterfeit drugs in the US
drug supply, an industry group has submitted a report to the Food
and Drug Administration (FDA) as a commentary on policy issues
surrounding prescription drug counterfeiting,...
Another arrest in fake Lipitor case
The US authorities have arrested another individual for suspected
involvement in the distribution of fake copies of Pfizer's
blockbuster cholesterol-lowering drug Lipitor (atorvastatin).
Effervescent route to improved solubility
CIMA is granted a US patent covering the use of effervescence to
improve the absorption of poorly-soluble drugs and target delivery
to specific areas of the GI tract.